Skip to main content
. 2022 Jun 21;5(3):625–636. doi: 10.20517/cdr.2022.34

Figure 1.

Figure 1

AdipoRon-mediated mechanisms and potential interconnection points to overcome gemcitabine resistance in PDAC. Schematic representation of the main metabolic and signaling pathways regulated by AdipoRon in PDAC cells. Red arrows indicate direct and indirect AdipoRon-related ways to hinder chemotherapy resistance.